Comparison of Confirmed Cytology Smears and Cell Blocks for Epidermal Growth Factor Receptor Mutation Testing in Non–Small Cell Lung Cancer

Clinical impact of subclonal EGFR T790M mutations in advanced-stage EGFR-mutant non-small-cell lung cancers

(2021) Tereza Vaclova et al.   Nature Communications

Evaluation of liquid based cytology in detection of EGFR mutation in NSCLC by large samples

(2020) Zhengwei Dong et al.   Journal of Thoracic Disease

Long term follow-up of EGFR mutated NSCLC cases

(2020) Gad Rennert et al.   Translational Oncology

Tyrosine Kinase Inhibitors for the Treatment of EGFR Mutation-Positive Non–Small-Cell Lung Cancer: A Clash of the Generations

(2019) Riyaz Shah et al.   Clinical Lung Cancer

EGFR mutation genotyping and ALK status determination in liquid-based cytology samples of non-small cell lung cancer

(2019) Yukitoshi Satoh et al.   VIRCHOWS ARCHIV

Comparison of plasma ctDNA and tissue/cytology-based techniques for the detection of EGFR mutation status in advanced NSCLC: Spanish data subset from ASSESS

(2018) E. Arriola et al.   Clinical & Translational Oncology

Liquid-Biopsy-Based Identification of EGFR T790M Mutation-Mediated Resistance to Afatinib Treatment in Patients with Advanced EGFR Mutation-Positive NSCLC, and Subsequent Response to Osimertinib

(2018) Maximilian J. Hochmair et al.   Targeted Oncology

Non–Small Cell Lung Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology

(2017) David S. Ettinger et al.   Journal of the National Comprehensive Cancer Network

Prolonged survival of patients with EGFR-mutated non-small cell lung cancer with solitary brain metastases treated with surgical resection of brain and lung lesions followed by EGFR TKIs

(2017) Qi Gui et al.   World Journal of Surgical Oncology

Acquisition of the T790M resistance mutation during afatinib treatment in EGFR tyrosine kinase inhibitor–naïve patients with non–small cell lung cancer harboring EGFR mutations

(2017) Kentaro Tanaka et al.   Oncotarget

10-year long-term survival of a metastaticEGFR-mutated nonsmall cell lung cancer patient

(2015) Emmanuelle Kempf et al.   EUROPEAN RESPIRATORY JOURNAL

AZD9291 in EGFR Inhibitor–Resistant Non–Small-Cell Lung Cancer

(2015) Pasi A. Jänne et al.   NEW ENGLAND JOURNAL OF MEDICINE

Cytology Smears as Diagnostic Material for EGFR Gene Testing in Non-small Cell Lung Cancer

(2015) Tomasz Powrózek et al.   TUMORI

Cytology Smears as Diagnostic Material for EGFR Gene Testing in Non-small Cell Lung Cancer

(2015) Tomasz Powrózek et al.   TUMORI JOURNAL

Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial

(2012) Rafael Rosell et al.   LANCET ONCOLOGY

Efficacy of Gefitinib for Elderly Patients with Advanced Non-Small Cell Lung Cancer Harboring Epidermal Growth Factor Receptor Gene Mutations: A Retrospective Analysis

(2010) Hironori Uruga et al.   INTERNAL MEDICINE

Gefitinib or Chemotherapy for Non–Small-Cell Lung Cancer with Mutated EGFR

(2010) Makoto Maemondo et al.   NEW ENGLAND JOURNAL OF MEDICINE